• Home
• About PBS/IC
  • Overview
  • Nomenclature
  • Causes
  • Diagnosis
    • Overview
    • Diagnostic flow
    • NIDDK
    • Differential diagnosis
  • Management
  • Patients
    • Patient quotes
    • Case studies
  • COB Foundation Survey
    • Overview
    • Diagnosis
    • Symptoms
    • Quality of life
    • Economic impact
  • Clinical Phenotyping
    • Background to UPOINT
    • What is UPOINT
    • UPOINT research
  • References
• Product information
  • Overview
  • Efficacy
    • Study 1
    • Study 2
  • Tolerability
  • Volume
  • Optimum dose of chondroitin sulfate
  • Budget impact
  • Mode of Action
  • Rationale for using chondroitin sulfate for PBS/IC
    • Importance of bladder GAG layer
    • Importance of chondroitin sulfate in bladder wall GAG layer
    • Dr Hurst Presentation video
  • How to administer Uracyst
  • Recommended treatment plan
  • References
• Resources
• KOL webcast
• Prescribing information & adverse incident reporting
• Request a call back

Home | About PBS/IC | Product information | Resources | KOL webcast | Prescribing information & adverse incident reporting | Request a call back | Contact us | Privacy | Sitemap | Copyright